Pfizer Inc. (NYSE: PFE) Stock: Can New Drug Pipeline Rescue Tumbling Share Price?
TLDR:
- Pfizer stock has fallen 16.44% over the past month, down 30% from its one-year high
- Starboard Value LP acquired a $1 billion stake in October 2024, pushing for management changes
- Pfizer forecasts 2025 revenues between $61-64 billion with focus shifting from COVID products
- The company pays a substantial dividend with current yield of 7.83%
- Despite strong Q4 earnings, the stock continues to struggle, with Q1 earnings expected April 29
Pfizer Inc. (PFE) shares have taken a beating in recent weeks. The pharmaceutical giant has seen its stock price
drop 16.44% over the past month, significantly worse than the broader market’s decline of 9.44% during the same period. Since reaching its one-year high on…
